{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:14:44Z","timestamp":1790018084942,"version":"4.0.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["01ED1509"],"award-info":[{"award-number":["01ED1509"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["01ED1509"],"award-info":[{"award-number":["01ED1509"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["01ED1509"],"award-info":[{"award-number":["01ED1509"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["01ED1509"],"award-info":[{"award-number":["01ED1509"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["01ED1509"],"award-info":[{"award-number":["01ED1509"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["01ED1509"],"award-info":[{"award-number":["01ED1509"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EURO-FINGERS","award":["01ED2003"],"award-info":[{"award-number":["01ED2003"]}]},{"name":"EURO-FINGERS","award":["01ED2003"],"award-info":[{"award-number":["01ED2003"]}]},{"name":"EURO-FINGERS","award":["01ED2003"],"award-info":[{"award-number":["01ED2003"]}]},{"name":"EURO-FINGERS","award":["01ED2003"],"award-info":[{"award-number":["01ED2003"]}]},{"name":"EURO-FINGERS","award":["01ED2003"],"award-info":[{"award-number":["01ED2003"]}]},{"name":"EURO-FINGERS","award":["01ED2003"],"award-info":[{"award-number":["01ED2003"]}]},{"name":"European Comission under the framework programme of the European Union LipiDiDiet","award":["211696"],"award-info":[{"award-number":["211696"]}]},{"name":"European Comission under the framework programme of the European Union LipiDiDiet","award":["211696"],"award-info":[{"award-number":["211696"]}]},{"name":"European Comission under the framework programme of the European Union LipiDiDiet","award":["211696"],"award-info":[{"award-number":["211696"]}]},{"name":"European Comission under the framework programme of the European Union LipiDiDiet","award":["211696"],"award-info":[{"award-number":["211696"]}]},{"name":"European Comission under the framework programme of the European Union LipiDiDiet","award":["211696"],"award-info":[{"award-number":["211696"]}]},{"name":"European Comission under the framework programme of the European Union LipiDiDiet","award":["211696"],"award-info":[{"award-number":["211696"]}]},{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is a very frequent neurodegenerative disorder characterized by an accumulation of amyloid-\u03b2 (A\u03b2). Acitretin, a retinoid-derivative and approved treatment for Psoriasis vulgaris,\n increases non-amyloidogenic Amyloid-Precursor-Protein-(APP)-processing, prevents A\u03b2-production and elicits cognitive improvement in AD mouse models. As an unintended side effect, acitretin could result in hyperlipidemia. Here, we analyzed the impact of acitretin on the lipidome in brain and liver tissue in the 5xFAD mouse-model. In line with literature, triglycerides were increased in liver accompanied by increased PCaa, plasmalogens and acyl-carnitines, whereas SM-species were decreased. In brain, these effects were partially enhanced or similar but also inverted. While for SM and plasmalogens similar effects were found, PCaa, TAG and acyl-carnitines showed an inverse effect in both tissues. Our findings emphasize, that potential pharmaceuticals to treat AD should be carefully monitored with respect to lipid-homeostasis because APP-processing itself modulates lipid-metabolism and medication might result in further and unexpected changes. Moreover, deducing effects of brain lipid-homeostasis from results obtained for other tissues should be considered cautiously. With respect to acitretin, the increase in brain plasmalogens might display a further positive probability in AD-treatment, while other results, such as decreased SM, indicate the need of medical surveillance for treated patients.<\/jats:p>","DOI":"10.1038\/s41598-021-94706-3","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T10:02:50Z","timestamp":1627380170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Shotgun lipidomics of liver and brain tissue of Alzheimer\u2019s disease model mice treated with acitretin"],"prefix":"10.1038","volume":"11","author":[{"given":"Anna A.","family":"Lauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Janitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"dos Santos Guilherme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Thu Thuy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornel M.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Schrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike S.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus O. W.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"94706_CR1","doi-asserted-by":"publisher","first-page":"3067126","DOI":"10.1155\/2018\/3067126","volume":"2018","author":"LM Oliveira","year":"2018","unstructured":"Oliveira, L. M., Teixeira, F. M. E. & Sato, M. N. Impact of retinoic acid on immune cells and inflammatory diseases. Mediat. Inflamm 2018, 3067126. https:\/\/doi.org\/10.1155\/2018\/3067126 (2018).","journal-title":"Mediat. Inflamm"},{"key":"94706_CR2","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1007\/s00018-016-2332-9","volume":"73","author":"A Comptour","year":"2016","unstructured":"Comptour, A. et al. Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects. Cell Mol. Life Sci. 73, 3823\u20133837. https:\/\/doi.org\/10.1007\/s00018-016-2332-9 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"94706_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/17425255.2018.1515198","volume":"14","author":"MS Heath","year":"2018","unstructured":"Heath, M. S., Sahni, D. R., Curry, Z. A. & Feldman, S. R. Pharmacokinetics of tazarotene and acitretin in psoriasis. Expert Opin. Drug Metab. Toxicol. 14, 919\u2013927. https:\/\/doi.org\/10.1080\/17425255.2018.1515198 (2018).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"94706_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2340\/00015555-1719","volume":"94","author":"S Piaserico","year":"2014","unstructured":"Piaserico, S. et al. Efficacy and safety of systemic treatments for psoriasis in elderly patients. Acta Derm Venereol. 94, 293\u2013297. https:\/\/doi.org\/10.2340\/00015555-1719 (2014).","journal-title":"Acta Derm Venereol."},{"key":"94706_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41598-018-19577-7","volume":"8","author":"S Reinhardt","year":"2018","unstructured":"Reinhardt, S. et al. Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer\u2019s disease hallmarks. Sci. Rep. 8, 1329. https:\/\/doi.org\/10.1038\/s41598-018-19577-7 (2018).","journal-title":"Sci. Rep."},{"key":"94706_CR6","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1096\/fj.08-121392","volume":"23","author":"F Tippmann","year":"2009","unstructured":"Tippmann, F., Hundt, J., Schneider, A., Endres, K. & Fahrenholz, F. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J 23, 1643\u20131654. https:\/\/doi.org\/10.1096\/fj.08-121392 (2009).","journal-title":"FASEB J"},{"key":"94706_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fnagi.2019.00182","volume":"11","author":"M Dos Santos Guilherme","year":"2019","unstructured":"Dos Santos Guilherme, M. et al. The synthetic retinoid acitretin increases IL-6 in the central nervous system of Alzheimer disease model mice and human patients. Front. Aging Neurosci. 11, 182. https:\/\/doi.org\/10.3389\/fnagi.2019.00182 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"94706_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI20864","volume":"113","author":"R Postina","year":"2004","unstructured":"Postina, R. et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456\u20131464. https:\/\/doi.org\/10.1172\/JCI20864 (2004).","journal-title":"J. Clin. Invest."},{"key":"94706_CR9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.4103\/1673-5374.259604","volume":"14","author":"BC Das","year":"2019","unstructured":"Das, B. C., Dasgupta, S. & Ray, S. K. Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Neural Regen. Res. 14, 1880\u20131892. https:\/\/doi.org\/10.4103\/1673-5374.259604 (2019).","journal-title":"Neural Regen. Res."},{"key":"94706_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111785","author":"MO Grimm","year":"2016","unstructured":"Grimm, M. O., Mett, J. & Hartmann, T. The Impact of vitamin E and other fat-soluble vitamins on Alzheimer s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms17111785 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"94706_CR11","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000001017","volume":"83","author":"K Endres","year":"2014","unstructured":"Endres, K. et al. Increased CSF APPs-alpha levels in patients with Alzheimer disease treated with acitretin. Neurology 83, 1930\u20131935. https:\/\/doi.org\/10.1212\/WNL.0000000000001017 (2014).","journal-title":"Neurology"},{"key":"94706_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/s0190-9622(89)70138-9","volume":"20","author":"AK Gupta","year":"1989","unstructured":"Gupta, A. K., Goldfarb, M. T., Ellis, C. N. & Voorhees, J. J. Side-effect profile of acitretin therapy in psoriasis. J. Am. Acad. Dermatol. 20, 1088\u20131093. https:\/\/doi.org\/10.1016\/s0190-9622(89)70138-9 (1989).","journal-title":"J. Am. Acad. Dermatol."},{"key":"94706_CR13","first-page":"300","volume":"68","author":"C Vahlquist","year":"1988","unstructured":"Vahlquist, C., Selinus, I. & Vessby, B. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis. Acta Derm. Venereol. 68, 300\u2013305 (1988).","journal-title":"Acta Derm. Venereol."},{"key":"94706_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/ijd.IJD_300_18","volume":"64","author":"VV Pai","year":"2019","unstructured":"Pai, V. V., Phadke, D., Shukla, P. & Naik, K. Fixed tapering dosage of acitretin in patients with psoriasis: a short-term analysis of clinical efficacy and its effects on biochemical parameters. Indian J. Dermatol. 64, 213\u2013216. https:\/\/doi.org\/10.4103\/ijd.IJD_300_18 (2019).","journal-title":"Indian J. Dermatol."},{"key":"94706_CR15","first-page":"85","volume":"6","author":"D Tsambaos","year":"1992","unstructured":"Tsambaos, D., Kalofoutis, A., Georgiou, S. & Koulocheris, A. Oral acitretin induces alterations in mouse liver phospholipid composition. In Vivo 6, 85\u201387 (1992).","journal-title":"In Vivo"},{"key":"94706_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000211313","volume":"7","author":"D Tsambaos","year":"1994","unstructured":"Tsambaos, D., Bolsen, K., Georgiou, S., Kalofoutis, A. & Goerz, G. Effects of oral administration of acitretin on rat liver microsomal phospholipids, P-450 content and monooxygenase activities. Skin Pharmacol. 7, 320\u2013323. https:\/\/doi.org\/10.1159\/000211313 (1994).","journal-title":"Skin Pharmacol."},{"key":"94706_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0167-4889(90)90108-p","volume":"1055","author":"V Carillet","year":"1990","unstructured":"Carillet, V. et al. In vitro interactions of the aromatic retinoids Ro 10\u20139359 (etretinate) and Ro 10\u20131670 (acitretin), its main metabolite, with human serum lipoproteins and albumin. Biochim. Biophys. Acta 1055, 98\u2013101. https:\/\/doi.org\/10.1016\/0167-4889(90)90108-p (1990).","journal-title":"Biochim. Biophys. Acta"},{"key":"94706_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JAD-180288","volume":"64","author":"SC Larsson","year":"2018","unstructured":"Larsson, S. C. & Markus, H. S. Does treating vascular risk factors prevent dementia and Alzheimer\u2019s disease? A systematic review and meta-analysis. J. Alzheimers Dis. 64, 657\u2013668. https:\/\/doi.org\/10.3233\/JAD-180288 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"94706_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.comppsych.2017.07.003","volume":"78","author":"H Xue","year":"2017","unstructured":"Xue, H. et al. Risk factors of transition from mild cognitive impairment to Alzheimer\u2019s disease and death: a cohort study. Compr. Psychiatry 78, 91\u201397. https:\/\/doi.org\/10.1016\/j.comppsych.2017.07.003 (2017).","journal-title":"Compr. Psychiatry"},{"key":"94706_CR20","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.bbamem.2007.02.014","volume":"1768","author":"EG Zinser","year":"2007","unstructured":"Zinser, E. G., Hartmann, T. & Grimm, M. O. Amyloid beta-protein and lipid metabolism. Biochim. Biophys. Acta 1768, 1991\u20132001. https:\/\/doi.org\/10.1016\/j.bbamem.2007.02.014 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"94706_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnmol.2017.00063","volume":"10","author":"MO Grimm","year":"2017","unstructured":"Grimm, M. O., Mett, J., Grimm, H. S. & Hartmann, T. APP function and lipids: a bidirectional link. Front. Mol. Neurosci. 10, 63. https:\/\/doi.org\/10.3389\/fnmol.2017.00063 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"94706_CR22","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1194\/jlr.R076331","volume":"58","author":"MOW Grimm","year":"2017","unstructured":"Grimm, M. O. W., Michaelson, D. M. & Hartmann, T. Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer\u2019s disease: a rationale for multi-nutrient dementia prevention. J. Lipid Res. 58, 2083\u20132101. https:\/\/doi.org\/10.1194\/jlr.R076331 (2017).","journal-title":"J. Lipid Res."},{"key":"94706_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00221-011-2975-6","volume":"217","author":"MO Grimm","year":"2012","unstructured":"Grimm, M. O., Rothhaar, T. L. & Hartmann, T. The role of APP proteolytic processing in lipid metabolism. Exp. Brain Res. 217, 365\u2013375. https:\/\/doi.org\/10.1007\/s00221-011-2975-6 (2012).","journal-title":"Exp. Brain Res."},{"key":"94706_CR24","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1016\/j.chroma.2011.07.073","volume":"1218","author":"MO Grimm","year":"2011","unstructured":"Grimm, M. O. et al. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer\u2019s disease human post mortem brains and mice model via mass spectrometry. J. Chromatogr. A 1218, 7713\u20137722. https:\/\/doi.org\/10.1016\/j.chroma.2011.07.073 (2011).","journal-title":"J. Chromatogr. A"},{"key":"94706_CR25","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.bbalip.2010.05.002","volume":"966\u2013974","author":"S Grosgen","year":"1801","unstructured":"Grosgen, S., Grimm, M. O., Friess, P. & Hartmann, T. Role of amyloid beta in lipid homeostasis. Biochim. Biophys. Acta 966\u2013974, 2010. https:\/\/doi.org\/10.1016\/j.bbalip.2010.05.002 (1801).","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl 1","key":"94706_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1471-4159.2007.04715.x","volume":"103","author":"T Hartmann","year":"2007","unstructured":"Hartmann, T., Kuchenbecker, J. & Grimm, M. O. Alzheimer\u2019s disease: the lipid connection. J. Neurochem. 103(Suppl 1), 159\u2013170. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04715.x (2007).","journal-title":"J. Neurochem."},{"key":"94706_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.dadm.2019.07.002","volume":"11","author":"DK Barupal","year":"2019","unstructured":"Barupal, D. K. et al. Sets of coregulated serum lipids are associated with Alzheimer\u2019s disease pathophysiology. Alzheimers Dement (Amst) 11, 619\u2013627. https:\/\/doi.org\/10.1016\/j.dadm.2019.07.002 (2019).","journal-title":"Alzheimers Dement (Amst)"},{"key":"94706_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fphys.2020.00598","volume":"11","author":"H Chew","year":"2020","unstructured":"Chew, H., Solomon, V. A. & Fonteh, A. N. Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies. Front. Physiol. 11, 598. https:\/\/doi.org\/10.3389\/fphys.2020.00598 (2020).","journal-title":"Front. Physiol."},{"key":"94706_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13555-020-00409-4","volume":"10","author":"DMW Balak","year":"2020","unstructured":"Balak, D. M. W., Gerdes, S., Parodi, A. & Salgado-Boquete, L. Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol. Ther. (Heidelb) 10, 589\u2013613. https:\/\/doi.org\/10.1007\/s13555-020-00409-4 (2020).","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"94706_CR30","doi-asserted-by":"publisher","first-page":"e0169952","DOI":"10.1371\/journal.pone.0169952","volume":"12","author":"X Xu","year":"2017","unstructured":"Xu, X., Su, L., Gao, Y. & Ding, Y. The prevalence of nonalcoholic fatty liver disease and related metabolic comorbidities was associated with age at onset of moderate to severe plaque psoriasis: a cross-sectional study. PLoS ONE 12, e0169952. https:\/\/doi.org\/10.1371\/journal.pone.0169952 (2017).","journal-title":"PLoS ONE"},{"key":"94706_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ejcn.2013.264","volume":"68","author":"R Otsuka","year":"2014","unstructured":"Otsuka, R. et al. Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly Japanese. Eur. J. Clin. Nutr. 68, 503\u2013509. https:\/\/doi.org\/10.1038\/ejcn.2013.264 (2014).","journal-title":"Eur. J. Clin. Nutr."},{"key":"94706_CR32","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","volume":"27","author":"KN Green","year":"2007","unstructured":"Green, K. N. et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27, 4385\u20134395. https:\/\/doi.org\/10.1523\/JNEUROSCI.0055-07.2007 (2007).","journal-title":"J. Neurosci."},{"key":"94706_CR33","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3945\/jn.108.096016","volume":"138","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw, W. J. & Bazan, N. G. Docosahexaenoic acid and the aging brain. J. Nutr. 138, 2510\u20132514. https:\/\/doi.org\/10.3945\/jn.108.096016 (2008).","journal-title":"J. Nutr."},{"key":"94706_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/BF00361430","volume":"18","author":"AG Archer","year":"1989","unstructured":"Archer, A. G., Nelson, M. C., Abbondanzo, S. L. & Bogumill, G. P. Case report 554: osteonecrosis at multiple sites as noted. Skeletal. Radiol. 18, 380\u2013384. https:\/\/doi.org\/10.1007\/BF00361430 (1989).","journal-title":"Skeletal. Radiol."},{"key":"94706_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.devcel.2013.01.013","volume":"24","author":"F Wilfling","year":"2013","unstructured":"Wilfling, F. et al. Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Dev. Cell 24, 384\u2013399. https:\/\/doi.org\/10.1016\/j.devcel.2013.01.013 (2013).","journal-title":"Dev. Cell"},{"key":"94706_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2011.07.013","volume":"14","author":"N Krahmer","year":"2011","unstructured":"Krahmer, N. et al. Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. Cell Metab. 14, 504\u2013515. https:\/\/doi.org\/10.1016\/j.cmet.2011.07.013 (2011).","journal-title":"Cell Metab."},{"key":"94706_CR37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","volume":"77","author":"X Han","year":"2001","unstructured":"Han, X., Holtzman, D. M. & McKeel, D. W. Jr. Plasmalogen deficiency in early Alzheimer\u2019s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168\u20131180. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00332.x (2001).","journal-title":"J. Neurochem."},{"key":"94706_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12944-019-1044-1","volume":"18","author":"XQ Su","year":"2019","unstructured":"Su, X. Q., Wang, J. & Sinclair, A. J. Plasmalogens and Alzheimer\u2019s disease: a review. Lipids Health Dis. 18, 100. https:\/\/doi.org\/10.1186\/s12944-019-1044-1 (2019).","journal-title":"Lipids Health Dis."},{"key":"94706_CR39","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1471-4159.2010.07070.x","volume":"116","author":"MO Grimm","year":"2011","unstructured":"Grimm, M. O. et al. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer\u2019s disease. J. Neurochem. 116, 916\u2013925. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07070.x (2011).","journal-title":"J. Neurochem."},{"key":"94706_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051149","author":"SH Law","year":"2019","unstructured":"Law, S. H. et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20051149 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"94706_CR41","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.bbalip.2010.05.013","volume":"784\u2013790","author":"RO Sanchez-Mejia","year":"1801","unstructured":"Sanchez-Mejia, R. O. & Mucke, L. Phospholipase A2 and arachidonic acid in Alzheimer\u2019s disease. Biochim. Biophys. Acta 784\u2013790, 2010. https:\/\/doi.org\/10.1016\/j.bbalip.2010.05.013 (1801).","journal-title":"Biochim. Biophys. Acta"},{"key":"94706_CR42","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/nn.2213","volume":"11","author":"RO Sanchez-Mejia","year":"2008","unstructured":"Sanchez-Mejia, R. O. et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer\u2019s disease. Nat. Neurosci. 11, 1311\u20131318. https:\/\/doi.org\/10.1038\/nn.2213 (2008).","journal-title":"Nat. Neurosci."},{"key":"94706_CR43","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"MO Grimm","year":"2005","unstructured":"Grimm, M. O. et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol. 7, 1118\u20131123. https:\/\/doi.org\/10.1038\/ncb1313 (2005).","journal-title":"Nat. Cell Biol."},{"key":"94706_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He, X., Huang, Y., Li, B., Gong, C. X. & Schuchman, E. H. Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol. Aging 31, 398\u2013408. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.05.010 (2010).","journal-title":"Neurobiol. Aging"},{"key":"94706_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","volume":"27","author":"LK Huang","year":"2020","unstructured":"Huang, L. K., Chao, S. P. & Hu, C. J. Clinical trials of new drugs for Alzheimer disease. J. Biomed. Sci. 27, 18. https:\/\/doi.org\/10.1186\/s12929-019-0609-7 (2020).","journal-title":"J. Biomed. Sci."},{"key":"94706_CR46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40266-015-0318-1","volume":"32","author":"JL Tan","year":"2015","unstructured":"Tan, J. L., Eastment, J. G., Poudel, A. & Hubbard, R. E. Age-related changes in hepatic function: an update on implications for drug therapy. Drugs Aging 32, 999\u20131008. https:\/\/doi.org\/10.1007\/s40266-015-0318-1 (2015).","journal-title":"Drugs Aging"},{"key":"94706_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071632","author":"MA Erickson","year":"2019","unstructured":"Erickson, M. A. & Banks, W. A. Age-associated changes in the immune system and blood(-)brain barrier functions. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20071632 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"94706_CR48","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1742-4658.2009.06889.x","volume":"276","author":"C Freese","year":"2009","unstructured":"Freese, C., Garratt, A. N., Fahrenholz, F. & Endres, K. The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1. FEBS J. 276, 1568\u20131580. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06889.x (2009).","journal-title":"FEBS J."},{"key":"94706_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000334300","volume":"10","author":"D Holthoewer","year":"2012","unstructured":"Holthoewer, D. et al. Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein. Neurodegener. Dis. 10, 224\u2013228. https:\/\/doi.org\/10.1159\/000334300 (2012).","journal-title":"Neurodegener. Dis."},{"key":"94706_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3389\/fnins.2019.00871","volume":"13","author":"N Bergau","year":"2019","unstructured":"Bergau, N., Maul, S., Rujescu, D., Simm, A. & Navarrete Santos, A. Reduction of glycolysis intermediate concentrations in the cerebrospinal fluid of Alzheimer\u2019s disease patients. Front. Neurosci. 13, 871. https:\/\/doi.org\/10.3389\/fnins.2019.00871 (2019).","journal-title":"Front. Neurosci."},{"key":"94706_CR51","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.14336\/AD.2019.0611","volume":"10","author":"AR Hipkiss","year":"2019","unstructured":"Hipkiss, A. R. Aging, Alzheimer\u2019s disease and dysfunctional glycolysis; similar effects of too much and too little. Aging Dis. 10, 1328\u20131331. https:\/\/doi.org\/10.14336\/AD.2019.0611 (2019).","journal-title":"Aging Dis."},{"key":"94706_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D. A. & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 20, 148\u2013160. https:\/\/doi.org\/10.1038\/s41583-019-0132-6 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"94706_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/jad-2006-9209","volume":"9","author":"SM de la Monte","year":"2006","unstructured":"de la Monte, S. M. & Wands, J. R. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer\u2019s disease. J. Alzheimers Dis. 9, 167\u2013181. https:\/\/doi.org\/10.3233\/jad-2006-9209 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"94706_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G. & Zhu, X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol. Neurodegener. 15, 30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6 (2020).","journal-title":"Mol. Neurodegener."},{"key":"94706_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF02536067","volume":"26","author":"M Soderberg","year":"1991","unstructured":"Soderberg, M., Edlund, C., Kristensson, K. & Dallner, G. Fatty acid composition of brain phospholipids in aging and in Alzheimer\u2019s disease. Lipids 26, 421\u2013425. https:\/\/doi.org\/10.1007\/BF02536067 (1991).","journal-title":"Lipids"},{"key":"94706_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1079\/BJN2002804","volume":"89","author":"AM Tully","year":"2003","unstructured":"Tully, A. M. et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer\u2019s disease: a case-control study. Br. J. Nutr. 89, 483\u2013489. https:\/\/doi.org\/10.1079\/BJN2002804 (2003).","journal-title":"Br. J. Nutr."},{"key":"94706_CR57","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/bmj.325.7370.932","volume":"325","author":"P Barberger-Gateau","year":"2002","unstructured":"Barberger-Gateau, P. et al. Fish, meat, and risk of dementia: cohort study. BMJ 325, 932\u2013933. https:\/\/doi.org\/10.1136\/bmj.325.7370.932 (2002).","journal-title":"BMJ"},{"key":"94706_CR58","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archneur.60.7.940","volume":"60","author":"MC Morris","year":"2003","unstructured":"Morris, M. C. et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 60, 940\u2013946. https:\/\/doi.org\/10.1001\/archneur.60.7.940 (2003).","journal-title":"Arch Neurol."},{"key":"94706_CR59","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","volume":"63","author":"EJ Schaefer","year":"2006","unstructured":"Schaefer, E. J. et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the framingham heart study. Arch. Neurol. 63, 1545\u20131550. https:\/\/doi.org\/10.1001\/archneur.63.11.1545 (2006).","journal-title":"Arch. Neurol."},{"key":"94706_CR60","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3945\/ajcn.2009.27580","volume":"90","author":"E Albanese","year":"2009","unstructured":"Albanese, E. et al. Dietary fish and meat intake and dementia in Latin America, China, and India: a 10\/66 dementia research group population-based study. Am. J. Clin. Nutr. 90, 392\u2013400. https:\/\/doi.org\/10.3945\/ajcn.2009.27580 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"94706_CR61","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","volume":"286","author":"MO Grimm","year":"2011","unstructured":"Grimm, M. O. et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J. Biol. Chem. 286, 14028\u201314039. https:\/\/doi.org\/10.1074\/jbc.M110.182329 (2011).","journal-title":"J. Biol. Chem."},{"key":"94706_CR62","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3945\/jn.109.113910","volume":"140","author":"GM Cole","year":"2010","unstructured":"Cole, G. M. & Frautschy, S. A. DHA may prevent age-related dementia. J. Nutr. 140, 869\u2013874. https:\/\/doi.org\/10.3945\/jn.109.113910 (2010).","journal-title":"J. Nutr."},{"key":"94706_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3945\/an.111.000893","volume":"3","author":"D Swanson","year":"2012","unstructured":"Swanson, D., Block, R. & Mousa, S. A. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv. Nutr. 3, 1\u20137. https:\/\/doi.org\/10.3945\/an.111.000893 (2012).","journal-title":"Adv. Nutr."},{"key":"94706_CR64","first-page":"409","volume":"10","author":"J Hayes","year":"2011","unstructured":"Hayes, J. & Koo, J. Depression and acitretin: a true association or a class labeling?. J. Drugs Dermatol. 10, 409\u2013412 (2011).","journal-title":"J. Drugs Dermatol."},{"key":"94706_CR65","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.adengl.2013.01.001","volume":"104","author":"G Carretero","year":"2013","unstructured":"Carretero, G. et al. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr. 104, 598\u2013616. https:\/\/doi.org\/10.1016\/j.adengl.2013.01.001 (2013).","journal-title":"Actas Dermosifiliogr."},{"key":"94706_CR66","doi-asserted-by":"publisher","unstructured":"Acitretin. React. Weekly 1756, 14. https:\/\/doi.org\/10.1007\/s40278-019-62893-y (2019).","DOI":"10.1007\/s40278-019-62893-y"},{"key":"94706_CR67","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0019-5154.35356","volume":"52","author":"ML Elsaie","year":"2007","unstructured":"Elsaie, M. L. Suicidal tendency in a psoriasis vulgaris patient under acitretin treatment. Indian J. Dermatol. 52, 164\u2013165. https:\/\/doi.org\/10.4103\/0019-5154.35356 (2007).","journal-title":"Indian J. Dermatol."},{"key":"94706_CR68","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0006-8993(95)00931-f","volume":"698","author":"L Ginsberg","year":"1995","unstructured":"Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I. & Gershfeld, N. L. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer\u2019s disease brain. Brain Res. 698, 223\u2013226. https:\/\/doi.org\/10.1016\/0006-8993(95)00931-f (1995).","journal-title":"Brain Res."},{"key":"94706_CR69","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.4049\/jimmunol.166.11.6749","volume":"166","author":"R Vankayalapati","year":"2001","unstructured":"Vankayalapati, R. et al. T cells enhance production of IL-18 by monocytes in response to an intracellular pathogen. J. Immunol. 166, 6749\u20136753. https:\/\/doi.org\/10.4049\/jimmunol.166.11.6749 (2001).","journal-title":"J. Immunol."},{"key":"94706_CR70","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/141240","volume":"2012","author":"TL Rothhaar","year":"2012","unstructured":"Rothhaar, T. L. et al. Plasmalogens inhibit APP processing by directly affecting gamma-secretase activity in Alzheimer\u2019s disease. ScientificWorldJournal 2012, 141240. https:\/\/doi.org\/10.1100\/2012\/141240 (2012).","journal-title":"ScientificWorldJournal"},{"key":"94706_CR71","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/NEN.0000000000000116","volume":"73","author":"Y Cui","year":"2014","unstructured":"Cui, Y. et al. Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics. J. Neuropathol. Exp. Neurol. 73, 954\u2013963. https:\/\/doi.org\/10.1097\/NEN.0000000000000116 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"94706_CR72","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-003-0007-9","volume":"110","author":"C Mulder","year":"2003","unstructured":"Mulder, C. et al. Decreased lysophosphatidylcholine\/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer\u2019s disease. J. Neural Transm. (Vienna) 110, 949\u2013955. https:\/\/doi.org\/10.1007\/s00702-003-0007-9 (2003).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"94706_CR73","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.clinbiochem.2010.04.072","volume":"43","author":"NJ Li","year":"2010","unstructured":"Li, N. J. et al. Plasma metabolic profiling of Alzheimer\u2019s disease by liquid chromatography\/mass spectrometry. Clin. Biochem. 43, 992\u2013997. https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.04.072 (2010).","journal-title":"Clin. Biochem."},{"key":"94706_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0005-2760(81)90195-8","volume":"663","author":"Y Krausz","year":"1981","unstructured":"Krausz, Y., Bar-On, H. & Shafrir, E. Origin and pattern of glucocorticoid-induced hyperlipidemia in rats. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity. Biochim. Biophys. Acta 663, 69\u201382. https:\/\/doi.org\/10.1016\/0005-2760(81)90195-8 (1981).","journal-title":"Biochim. Biophys. Acta"},{"key":"94706_CR75","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7196\/samj.7979","volume":"104","author":"IL Ross","year":"2014","unstructured":"Ross, I. L. & Marais, A. D. The influence of glucocorticoids on lipid and lipoprotein metabolism and atherosclerosis. S. Afr. Med. J. 104, 671\u2013674. https:\/\/doi.org\/10.7196\/samj.7979 (2014).","journal-title":"S. Afr. Med. J."},{"key":"94706_CR76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0190-9622(92)70213-y","volume":"27","author":"MJ Stiller","year":"1992","unstructured":"Stiller, M. J. et al. Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease. J. Am. Acad. Dermatol. 27, 434\u2013438. https:\/\/doi.org\/10.1016\/0190-9622(92)70213-y (1992).","journal-title":"J. Am. Acad. Dermatol."},{"key":"94706_CR77","doi-asserted-by":"publisher","unstructured":"Cyclosporin and changes in lipid and carbohydrate metabolism. Reactions 141, 4. https:\/\/doi.org\/10.1007\/BF03267801 (1986).","DOI":"10.1007\/BF03267801"},{"key":"94706_CR78","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/695413","volume":"2011","author":"MO Grimm","year":"2011","unstructured":"Grimm, M. O. et al. Intracellular APP domain regulates serine-palmitoyl-CoA transferase expression and is affected in Alzheimer\u2019s disease. Int. J. Alzheimers Dis. 2011, 695413. https:\/\/doi.org\/10.4061\/2011\/695413 (2011).","journal-title":"Int. J. Alzheimers Dis."},{"key":"94706_CR79","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/acel.12183","volume":"13","author":"A Robinson","year":"2014","unstructured":"Robinson, A. et al. Upregulation of PGC-1alpha expression by Alzheimer\u2019s disease-associated pathway: presenilin 1\/amyloid precursor protein (APP)\/intracellular domain of APP. Aging Cell 13, 263\u2013272. https:\/\/doi.org\/10.1111\/acel.12183 (2014).","journal-title":"Aging Cell"},{"key":"94706_CR80","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.bbadis.2013.09.015","volume":"1248\u20131257","author":"AM Swomley","year":"1842","unstructured":"Swomley, A. M. et al. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim. Biophys. Acta 1248\u20131257, 2014. https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.015 (1842).","journal-title":"Biochim. Biophys. Acta"},{"key":"94706_CR81","doi-asserted-by":"publisher","first-page":"611","DOI":"10.18388\/abp.2007_3235","volume":"54","author":"M Chalimoniuk","year":"2007","unstructured":"Chalimoniuk, M. et al. Amyloid beta enhances cytosolic phospholipase A2 level and arachidonic acid release via nitric oxide in APP-transfected PC12 cells. Acta Biochim. Pol. 54, 611\u2013623 (2007).","journal-title":"Acta Biochim. Pol."},{"key":"94706_CR82","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/cne.24551","volume":"527","author":"JL Bundy","year":"2019","unstructured":"Bundy, J. L., Vied, C., Badger, C. & Nowakowski, R. S. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer\u2019s disease: a multi-omic analysis. J. Comp. Neurol. 527, 462\u2013475. https:\/\/doi.org\/10.1002\/cne.24551 (2019).","journal-title":"J. Comp. Neurol."},{"key":"94706_CR83","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06.2006 (2006).","journal-title":"J. Neurosci."},{"key":"94706_CR84","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF (2008).","journal-title":"FASEB J."},{"key":"94706_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith, P. K. et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76\u201385. https:\/\/doi.org\/10.1016\/0003-2697(85)90442-7 (1985).","journal-title":"Anal. Biochem."},{"key":"94706_CR86","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1038\/srep06581","volume":"4","author":"M Li","year":"2014","unstructured":"Li, M., Butka, E. & Wang, X. Comprehensive quantification of triacylglycerols in soybean seeds by electrospray ionization mass spectrometry with multiple neutral loss scans. Sci. Rep. 4, 6581. https:\/\/doi.org\/10.1038\/srep06581 (2014).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94706-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:42:15Z","timestamp":1670067735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94706-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94706"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94706-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15301"}}